Company: SMNR
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001193125-25-277536
Chunk: 10

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 6
Chunk 10
---
nur Pharmaceuticals, Inc.
     S-4
     333-283019 
     10.24.1
     July 23, 2025

     10.3
     Stock Issuance Agreement, dated as of July 22, 2025, by and between Semnur Pharmaceuticals, Inc. and the party named therein
     S-4
     333-283019 
     10.27
     July 23, 2025

     10.4
     Amendment to Advisory Services Agreement, dated as of July 22, 2025, by and between JW Investment Management Company Limited and Semnur Pharmaceuticals, Inc.
     S-4
     333-283019 
     10.29
     July 23, 2025

     10.5#
     Amended and Restated Registration Rights Agreement, dated as of September 22, 2025, by and among Semnur Pharmaceuticals, Inc., Scilex Holding Company and certain other securityholders
     8-K
     001-41351
     10.2
     September 26, 2025

     10.6
     Securities Purchase Agreement, dated as of August 20, 2025, by and among Denali Capital Acquisition Corp., Semnur Pharmaceuticals, Inc. and the Buyers thereto
     Filed herewith

     10.7
     Limited Amendment Letter Agreement, dated September 22, 2025, by and among Denali Capital Acquisition Corp., Semnur Pharmaceuticals, Inc. and the investor listed therein
     8-K 
     001-41351 
     10.13 
     September 26, 2025